Clinical Trial Update: Single-arm Study to Assess the Safety of Hydromorphone Hydrochloride by Intrathecal Administration [Phase 3]

View source ↗

Summary

A single-arm Phase 3 trial evaluating the safety of intrathecal hydromorphone hydrochloride for chronic pain has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Hydromorphone hydrochloride (hydromorphone hydrochloride)

Snippet

Sponsor: Piramal Critical Care, Ltd. | Conditions: Chronic Pain | Phase 3 | Status: COMPLETED | Results posted: 2021-08-25